$RARE Ultragenyx Pharmaceutical Inc. Insider Trading Week 24/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. in week 24/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2018 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Sell | S | 82.77 | 1,226 | 101,476 | 14,181 | 15.4 K to 14.2 K (-7.96 %) |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Payment of Exercise | F | 85.31 | 649 | 55,366 | 15,407 | 16.1 K to 15.4 K (-4.04 %) |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Grant | A | 0.00 | 3,000 | 0 | 4,875 | 1.9 K to 4.9 K (+160.00 %) |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | SIEGALL CLAY B | Director | Grant | A | 0.00 | 3,000 | 0 | 6,750 | 3.8 K to 6.8 K (+80.00 %) |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | NARACHI MICHAEL | Director | Grant | A | 0.00 | 3,000 | 0 | 6,750 | 3.8 K to 6.8 K (+80.00 %) |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Grant | A | 0.00 | 3,000 | 0 | 11,750 | 8.8 K to 11.8 K (+34.29 %) |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Grant | A | 0.00 | 3,000 | 0 | 6,750 | 3.8 K to 6.8 K (+80.00 %) |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Aliski William | Director | Grant | A | 0.00 | 3,000 | 0 | 76,360 | 73.4 K to 76.4 K (+4.09 %) |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
| Jun 20 2018 | RARE | Ultragenyx Pharmac ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,000 | 0 | 6,750 | 3.8 K to 6.8 K (+80.00 %) |